Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study

Hanane Yousfi , Carole Cassagne (1) , Stephane Ranque (1) , Jean-Marc Rolain (2) , Fadi Bittar (2)

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes
2 MEPHI - Microbes évolution phylogénie et infections

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Hanane Yousfi, Carole Cassagne, Stephane Ranque, Jean-Marc Rolain, Fadi Bittar. Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study. Antimicrobial Agents and Chemotherapy, 2019, ⟨10.1128/AAC.00263-19⟩. ⟨hal-02263610⟩